Q1 2025 Holdings
Filed 2025-05-15 | 64 holdings | $2.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc | DEBT 1.250% 2/1 | 40131MAD1 | $227.4M | $219,454,000 | 8.0% |
| Novocure LTD | NOTE 11/0 | 67011XAB9 | $136.6M | $140,834,000 | 4.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $131.8M | 1,191,925 | 4.6% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $101.0M | 2,977,951 | 3.6% |
| Repligen Corp | NOTE 1.000%12/1 | 759916AD1 | $95.8M | $98,000,000 | 3.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $95.2M | 160,849 | 3.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $90.9M | 2,709,875 | 3.2% |
| Irhythm Technologies Inc | NOTE 1.500% 9/0 | 450056AB2 | $89.7M | $86,000,000 | 3.2% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $87.9M | $101,381,000 | 3.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $84.3M | 530,530 | 3.0% |
| Ironwood Pharmaceuticals Inc | NOTE 1.500% 6/1 | 46333XAH1 | $82.5M | $92,740,000 | 2.9% |
| CG Oncology Inc(CGON) | COM | 156944100 | $80.4M | 3,283,317 | 2.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $72.3M | 400,744 | 2.5% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $72.0M | $62,838,000 | 2.5% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $63.6M | 127,733 | 2.2% |
| Danaher Corporation(DHR) | COM | 235851102 | $63.4M | 309,339 | 2.2% |
| Glaukos Corp(GKOS) | COM | 377322102 | $61.5M | 624,435 | 2.2% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $59.6M | 840,945 | 2.1% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $58.2M | 556,391 | 2.0% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $57.5M | 1,540,362 | 2.0% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $57.5M | 854,884 | 2.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $56.5M | 1,327,327 | 2.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $54.1M | 2,458,808 | 1.9% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $48.2M | 302,410 | 1.7% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $43.8M | $48,594,000 | 1.5% |
| Immunocore Hldgs PLC | NOTE 2.500% 2/0 | 45258DAB1 | $43.8M | $51,828,000 | 1.5% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $43.6M | 1,962,909 | 1.5% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $43.6M | 88,000 | 1.5% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $43.2M | 4,259,429 | 1.5% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $41.6M | 2,578,404 | 1.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $38.9M | 439,968 | 1.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $37.9M | 3,621,344 | 1.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $36.1M | 1,652,334 | 1.3% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $35.7M | 4,803,794 | 1.3% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $34.7M | 1,435,955 | 1.2% |
| Penumbra Inc(PEN) | COM | 70975L107 | $29.4M | 110,128 | 1.0% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $28.2M | 2,162,803 | 1.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $28.0M | 3,536,853 | 1.0% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $27.3M | 1,107,770 | 1.0% |
| Harrow Inc(HROW) | COM | 415858109 | $25.5M | 956,839 | 0.9% |
| Dexcom Inc | NOTE 0.375% 5/1 | 252131AM9 | $22.8M | $25,450,000 | 0.8% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $18.5M | 8,353,287 | 0.6% |
| Dexcom Inc | NOTE 0.250%11/1 | 252131AK3 | $18.0M | $18,500,000 | 0.6% |
| Xencor Inc(XNCR) | COM | 98401F105 | $17.6M | 1,655,690 | 0.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $16.6M | 106,713 | 0.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $16.1M | 1,572,426 | 0.6% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $16.1M | 48,690 | 0.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $15.0M | 234,500 | 0.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $14.3M | 1,461,826 | 0.5% |
| Repligen Corp(RGEN) | COM | 759916109 | $10.4M | 81,656 | 0.4% |